Entrada Therapeutics, Inc. (TRDA)
5.25
+0.56
(+11.94%)
USD |
NASDAQ |
Nov 10, 16:00
5.255
0.00 (0.00%)
After-Hours: 20:00
Entrada Therapeutics Market Cap : 205.54M for Nov. 10, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 10, 2026 | 205.54M |
| November 09, 2026 | 183.61M |
| November 06, 2026 | 191.44M |
| November 05, 2026 | 178.13M |
| November 04, 2026 | 198.10M |
| November 03, 2026 | 184.79M |
| November 02, 2026 | 198.97M |
| October 30, 2026 | 176.58M |
| October 29, 2026 | 171.32M |
| October 28, 2026 | 188.45M |
| October 27, 2026 | 171.71M |
| October 26, 2026 | 184.95M |
| October 23, 2026 | 171.71M |
| October 22, 2026 | 184.17M |
| October 21, 2026 | 181.06M |
| October 20, 2026 | 194.29M |
| October 19, 2026 | 187.67M |
| October 16, 2026 | 170.15M |
| October 15, 2026 | 186.12M |
| October 14, 2026 | 177.16M |
| October 13, 2026 | 189.23M |
| October 12, 2026 | 214.15M |
| October 09, 2026 | 220.77M |
| October 08, 2026 | 215.32M |
| October 07, 2026 | 218.43M |
| Date | Value |
|---|---|
| October 06, 2026 | 211.04M |
| October 05, 2026 | 213.37M |
| October 02, 2026 | 209.48M |
| October 01, 2026 | 221.16M |
| September 30, 2026 | 247.25M |
| September 29, 2026 | 243.74M |
| September 28, 2026 | 242.19M |
| September 25, 2026 | 239.85M |
| September 24, 2026 | 242.19M |
| September 23, 2026 | 253.09M |
| September 22, 2026 | 261.27M |
| September 21, 2026 | 258.54M |
| September 18, 2026 | 262.82M |
| September 17, 2026 | 268.66M |
| September 16, 2026 | 268.27M |
| September 15, 2026 | 267.88M |
| September 14, 2026 | 274.50M |
| September 11, 2026 | 264.77M |
| September 10, 2026 | 249.97M |
| September 09, 2026 | 276.84M |
| September 08, 2026 | 292.80M |
| September 04, 2026 | 277.62M |
| September 03, 2026 | 279.18M |
| September 02, 2026 | 284.24M |
| September 01, 2026 | 275.28M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Prime Medicine, Inc. | 704.88M |
| Arrowhead Pharmaceuticals, Inc. | 6.916B |
| Oncolytics Biotech, Inc. | 47.59M |
| Sangamo Therapeutics, Inc. | 45.57M |
| Sarepta Therapeutics, Inc. | 1.761B |
Market Cap Related Metrics
| PS Ratio | 55.46 |
| PEG Ratio | -0.0256 |
| Price to Book Value | 1.036 |
| Price | 5.25 |
| Earnings Yield | -73.17% |
| PEGY Ratio | -0.0256 |